Background: Individuals with two or more first-degree relatives who have had aneurysmal subarachnoid haemorrhage (aSAH) have an increased risk of aneurysms and aSAH. We investigated the yield of long-term serial screening for intracranial aneurysms in these individuals.
Background: High blood pressure is a prognostic factor for acute stroke, but blood pressure variability might also independently predict outcome. We assessed the prognostic value of blood pressure variability in participants of INTERACT2, an open-label randomised controlled trial
Background and Purpose: We aimed to establish the prevalence, characteristics, and outcomes of intracranial atherosclerosis (ICAS) in China by a large, prospective, multicenter study.
Background and Purpose: Predictors of outcome after aneurysmal subarachnoid hemorrhage have been determined previously through hypothesis-driven methods that often exclude putative covariates and require a priori knowledge of potential confounders. Here, we apply a data-driven approach, principal component analysis, to identify baseline patient phenotypes that may predict neurological outcomes.
Background and Purpose: Cerebral autoregulation may be impaired in the early days after subarachnoid hemorrhage (SAH). The purpose of this study was to examine the relationship between cerebral autoregulation and angiographic vasospasm (aVSP) and radiographic delayed cerebral ischemia (DCI) in patients with SAH.
Background and Purpose: Progression of asymptomatic carotid stenoses with >50% luminal narrowing is associated with an increased risk of stroke. The significance of the progression rate in these patients is unknown. The main aim of this study was to evaluate the rate of change of carotid luminal narrowing over 1 year, as a risk factor for ipsilateral ischemic events, in patients with a >50% asymptomatic carotid stenosis. Secondary aims were to establish the incidence of changes in carotid luminal narrowing and establish additional risk factors for ipsilateral neurological events.
Background and Purpose: Nonlacunar cerebral infarcts are presumed to be caused by thromboembolism from the heart or extracranial arteries, whereas lacunar infarcts are thought to be caused by small vessel disease. We investigated to what extent arterial calcifications differ between nonlacunar and lacunar ischemic strokes.
Background and Purpose: The efficacy of intra-arterial treatment remains uncertain. Because most centers performing IAT use noncontrast CT (NCCT) imaging, it is critical to understand the impact of NCCT findings on treatment outcomes. This study aimed to compare functional independence and safety among patients undergoing intra-arterial treatment stratified by the extent of ischemic change on pretreatment NCCT.
Background and Purpose: Several prognostic scores have been developed to predict the risk of symptomatic intracranial hemorrhage (sICH) after ischemic stroke thrombolysis. We compared the performance of these scores in a multicenter cohort.
Objectives: This single-center, randomized, clinical trial was designed to determine the 10-year comparative efficacy and durability of carotid angioplasty and stenting (CAS) versus carotid endarterectomy (CEA) in preventing ipsilateral ischemic stroke in symptomatic and asymptomatic patients with high-grade carotid artery stenosis.
The answer to the question “What is the optimal management of patients with carotid artery disease?” remains hotly debated and contentious. In the 1990s, the elements of this debate were focused on the relative merits of carotid endarterectomy (CEA) versus medical therapy (basically, aspirin), which most physicians considered settled by 4 randomized clinical trials in patients with symptomatic (1,) and asymptomatic (3,) carotid stenosis. Taken together, these trials formed the base of evidence that supported the recommendations for CEA in symptomatic carotid stenosis >50% and in asymptomatic carotid stenosis >70%. In the last 15 years, the findings of these studies have been challenged on the basis of 2 important therapeutic innovations: one in pharmacological approaches to coronary, peripheral, and cerebrovascular atherosclerosis, and the other in the development of minimally invasive techniques for carotid revascularization relying on carotid artery stenting (CAS) and embolic protection devices (EPDs). From a clinical trials perspective alone, more than $100 million have been devoted to studies of the technique of carotid revascularization, whereas there are no large-scale clinical trials of optimal medical therapy for stroke prevention in patients with severe carotid stenosis.
Objectives: This study sought to characterize usage and outcomes of carotid stenting platforms.
Comparative effectiveness research (CER) is a theme that will play an increasingly important role in the discourse of medical care. The Institute of Medicine defines CER as “the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care” (1). Most commonly, CER is used in the context of the politically-charged environment surrounding the Affordable Care Act, in which the explicitly stated purpose of CER is to rein in the growth of healthcare costs, largely by demanding evidence that newer, more expensive modalities be demonstrated to be more clinically effective and cost-effective than less expensive modalities as a condition for reimbursement 2. Whereas these are the principal domains for policy-makers and payers, clinical providers are also concerned with a somewhat more parochial issue: Given that we confront a clinical issue with a particular approach (e.g., a procedure such as carotid artery stenting [CAS]), which of several available alternative tools is the best for conducting the procedure?
Objectives: The purpose of this study was to evaluate and compare outcomes of patients undergoing carotid artery stenting (CAS) for ipsilateral restenosis, after either previous CAS or carotid artery endarterectomy (CEA) (CAS-R group), with those of patients who had CAS performed for de novo carotid atherosclerotic stenosis (CAS-DN group).
Background and Purpose: Embolic protection devices (EPD) may provide a mechanism to reduce peri-procedural strokes. They are advocated by consensus guidelines and mandated for Medicare reimbursement. However, outcomes data remain mixed. We aimed to characterize the population of patients undergoing unprotected carotid artery stenting (CAS) and assess the utility of distal filter EPD (F-EPD) in elective CAS.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos